Freezing of Gait Questionnaire

1. Abstract

The Freezing of Gait Questionnaire (FOGQ) is a validated, self-administered patient-reported outcome measure developed by Nir Giladi and colleagues in 1999 to evaluate the presence, frequency, severity, and functional impact of freezing of gait (FOG) in individuals diagnosed with Parkinson’s disease (PD) and related parkinsonian syndromes. Freezing of gait is defined clinically as a brief, episodic absence or marked reduction of forward progression of the feet despite the intention to walk. The FOGQ comprises 6 ordinal items scored on a 5-point scale (ranging from 0 to 4), producing a total cumulative score between 0 and 24, where higher scores represent greater severity of gait impairment and freezing behavior. Structurally, the instrument assesses two core clinical domains: general gait disruption and functional mobility (Items 1 and 2, corresponding to activities and participation limitations under the International Classification of Functioning, Disability and Health [ICF] framework), and the specific phenomenological manifestations of freezing, including frequency, maximum duration, start hesitation, and turning hesitation (Items 3 through 6). Psychometric evaluations demonstrate robust internal consistency (Cronbach’s alpha typically ranging from 0.83 to 0.94), exceptional test-retest reliability (intraclass correlation coefficients [ICC] between 0.84 and 0.96), and strong convergent validity with motor rating scales, specifically the Movement Disorder Society-Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) Part III motor examination and Part II motor experiences of daily living. Exploratory and confirmatory factor analyses generally substantiate a unidimensional construct or a robust two-factor bifactor structure reflecting gait impairment alongside focal episodic freezing severity. The FOGQ serves as an indispensable clinical and research endpoint for tracking disease progression, titrating dopaminergic pharmacotherapy, optimizing deep brain stimulation parameters, and tailoring physical therapy interventions.

2. Keywords

Freezing of Gait Questionnaire, FOGQ, Parkinson’s disease, freezing of gait, motor block, gait disturbance, postural instability, movement disorders, psychometrics, gait hesitation

3. Authors

The original Freezing of Gait Questionnaire was conceived, operationalized, and clinically validated by an interdisciplinary team of movement disorder neurologists and clinical neuroscientists at the Movement Disorders Unit of the Tel-Aviv Sourasky Medical Center and the Sackler Faculty of Medicine at Tel Aviv University, Tel Aviv, Israel:

• Nir Giladi, MD — Professor of Neurology, Department of Neurology and Movement Disorders Unit, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
• Hagar Shabtai, MD — Movement Disorders Unit, Department of Neurology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
• Eli S. Simon, MD — Department of Neurology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
• Sara Biran, MD — Department of Neurology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
• J. Tal, MSc — Biostatistics and Clinical Epidemiological Methodology, Tel Aviv University, Tel Aviv, Israel.
• Amos D. Korczyn, MD, MSc — Sieratzki Professor of Neurology, Department of Neurology, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.

Subsequent linguistic cross-cultural validations, notably the widely adopted Dutch version, were authored by S. H. J. Keus, M. Munneke, and colleagues under the auspices of the ParkinsonNet initiative in the Netherlands (Keus et al., 2006). A revised version incorporating instructional video exemplars (the New Freezing of Gait Questionnaire or NFOG-Q) was later validated by Nieuwboer and colleagues in 2009.

4. Purpose

Freezing of gait represents one of the most disabling, paroxysmal, and least understood motor complications observed in advanced Parkinson’s disease and atypical parkinsonian disorders such as progressive supranuclear palsy and multiple system atrophy. Patients characteristically describe a distressing subjective sensation wherein their “feet feel glued to the floor,” rendering them unable to take a step despite an urgent cognitive intent to ambulate. Because FOG is notoriously unpredictable, context-dependent, and readily suppressed or elicited by environmental triggers, emotional states, and clinic observation (a phenomenon often termed “the white-coat effect” where anxiety or focused attention transiently mitigates or exacerbates the symptom), objective laboratory or in-clinic gait assessments frequently fail to capture the true incidence and functional toll of freezing episodes. The Freezing of Gait Questionnaire was created to overcome these diagnostic and observational limitations by providing a standardized, ecologically valid, patient-reported assessment capable of aggregating the individual’s habitual daily experiences over an extended temporal window.

Clinically, the purpose of the FOGQ is multifaceted:

• Diagnostic Stratification: To establish whether an individual exhibits freezing behavior (“freezers” vs. “non-freezers”), facilitating timely pharmacological, neurosurgical, and rehabilitative stratification.
• Quantification of Symptom Severity: To grade the continuum of freezing severity, tracking temporal fluctuations associated with the “on-off” dopaminergic response cycle and the long-term neurodegenerative trajectory.
• Fall Risk Profiling: Because freezing episodes—particularly start hesitation and turning hesitation—cause sudden center-of-mass perturbations without adequate compensatory stepping, elevated FOGQ scores directly correlate with high fall frequency, secondary fracture morbidity, fear of falling, and loss of functional autonomy.
• Treatment Optimization: To serve as a responsive primary or secondary outcome measure in clinical trials testing pharmacological therapies (such as levodopa, monoamine oxidase B inhibitors, and catechol-O-methyltransferase inhibitors), neurosurgical interventions (including subthalamic nucleus and pedunculopontine nucleus deep brain stimulation), and tailored motor-cognitive rehabilitation strategies (e.g., rhythmic auditory cueing, visual stepping lines, and treadmill training).

The theoretical rationale rests upon capturing patient subjective reports across the World Health Organization’s ICF framework, bridging body function impairments (ICF Level I: episodic motor arrests, duration, and triggering contexts) and personal activity restrictions (ICF Level II: independence during walking and disruption of activities of daily living).

5. Psychological and Neurobehavioral Construct

The construct assessed by the FOGQ spans complex neurobehavioral, cognitive-motor, and biomechanical domains. Freezing is fundamentally an intermittent failure of motor automaticity, executive attentional set-shifting, and bilateral coordination. The 6 items of the FOGQ collectively measure this multifaceted construct across several distinct dimensions:

1. Global Gait Disturbance and Activity Disruption (Items 1 and 2)

Items 1 and 2 assess general baseline locomotion in the patient’s worst functional state and the consequent interference with activities of daily living (ADLs). Rather than measuring pure motor velocity, this subscale captures the subjective burden of mobility disability. Patients who experience severe motor fluctuations or secondary muscle rigidity must constantly deploy conscious attentional reserves to preserve locomotion, transforming a formerly automatic spinal-brainstem motor synergy into a laborious, high-demand cognitive task. Disruption of daily activities reflects secondary behavioral adaptations, such as activity avoidance, agoraphobia-like social withdrawal, and dependence on physical caregivers or assistive mobility aids.

2. Core Phenomenological Freezing Perception (Item 3)

Item 3 directly addresses the paroxysmal subjective perception of kinetic blockade: the classic sensation that one’s feet are mechanically anchored or adhesively glued to the walking surface. This item evaluates both the frequency and situational broadness of freezing across straight-line forward walking, pivoting, and initiation. Neurobiologically, this corresponds to an abrupt paroxysmal breakdown in basal ganglia-thalamocortical motor loops, characterized by rapid 3–8 Hz trembling of the legs without forward translation, or complete akinesia.

3. Temporal Duration and Motor Blockade Severity (Item 4)

Item 4 evaluates the chronological length of the patient’s most extreme freezing episodes, graduating from brief 1–2 second micro-arrests up to prolonged blocks exceeding 30 seconds. The duration of motor arrests indexes the severity of transient executive and frontostriatal dysregulation; longer episodes reflect an inability to spontaneously recruit secondary cortical pathways or voluntary compensation mechanisms to bypass the dysfunctional striatal circuitry.

4. Context-Specific Triggers: Start and Turning Hesitations (Items 5 and 6)

Items 5 and 6 target the two most ecologically prevalent and hazardous kinematic triggers: start hesitation (akinesia occurring during the initiation of the initial step from a static standing position) and turning hesitation (motor arrest occurring during axial reorientation and circular trajectory execution). Start hesitation reflects a failure of motor programming: the preparatory anticipatory postural adjustments (APAs)—wherein the center of pressure normally shifts posterolaterally to unweight the swing leg—are decoupled, fragmented, or hypometric, leaving the feet immobilized. Turning hesitation involves heightened cognitive and sensorimotor demands: changing direction requires asymmetrical inter-limb coordination, head-trunk-pelvis decoupling, and continuous online perceptual recalibration. The breakdown during turning highlights vulnerable interactions between the supplementary motor area, the basal ganglia, and the pedunculopontine nucleus.

6. Theoretical Framework

The theoretical framework underpinning the Freezing of Gait Questionnaire integrates contemporary models of basal ganglia neurophysiology, motor automaticity degradation, and cognitive-motor cross-talk in neurodegenerative syndromes.

The Threshold and Information-Overload Hypotheses

A leading conceptual model formulated by Plotnik, Giladi, and Hausdorff posits that freezing arises when cumulative sensorimotor and cognitive deficits surpass a critical threshold. Under normal physiological conditions, continuous locomotion is orchestrated by subcortical central pattern generators in the spinal cord and mesencephalic locomotor region, modulated effortlessly by basal ganglia striatonigral loops without substantial cortical oversight. In Parkinson’s disease, striatal dopamine depletion disrupts the rhythmicity, symmetry, and bilateral coordination of left-right phase stepping. When ambient processing demands surge—such as navigating an obstacle-dense corridor, traversing a narrow doorway, responding to an environmental distraction, or performing a concurrent dual-task (e.g., carrying a conversation while walking)—the already compromised striatal circuits experience an acute informational bottleneck. The system exceeds its compensatory threshold, resulting in motor output shutdown and sudden freezing.

The Executive-Attentional and Perceptual Model

A complementary neuropsychological framework advanced by Lewis and Barker highlights frontostriatal disconnection, implicating executive dysfunction—specifically cognitive inflexibility, impaired set-shifting, and response inhibition failure—in the genesis of FOG. When a walking individual encounters a visual constriction (such as a threshold or doorframe), the brain must swiftly shift motor plans from rapid automatic stepping to measured, deliberate gait. Freezers demonstrate marked pathology in the hyperdirect pathway linking the pre-supplementary motor area and subthalamic nucleus. As conflict resolution breaks down, conflicting motor programs fire simultaneously, resulting in co-contraction of antagonist flexor-extensor lower limb musculature, high-frequency trembling, and complete kinesia arrest. The FOGQ operationalizes these diverse cognitive-perceptual paradigms into an accessible, ecologically valid 6-item rubric.

7. Validity

The psychometric validity of the Freezing of Gait Questionnaire has been rigorously established across numerous independent global cohorts, demonstrating solid construct, convergent, criterion, and discriminant validity.

Construct and Convergent Validity

In the seminal validation investigation conducted by Giladi et al. (2000), the FOGQ demonstrated robust convergent validity when correlated against established clinical indices of Parkinson’s disease severity:

• MDS-UPDRS Motor Examination (Part III): Strong positive correlations with total motor scores (Pearson $r = 0.55$ to $0.71$, $p < 0.001$), with notably stronger associations observed when isolating the axial/postural stability and gait sub-scores ($r = 0.68$ to $0.78$).
• UPDRS Activities of Daily Living (Part II): Highly significant positive correlations ($r = 0.63$ to $0.74$, $p < 0.001$), confirming that greater freezing severity corresponds directly to diminished independent functional performance.
• Hoehn and Yahr Staging: Significant rank correlations (Spearman $rho = 0.50$ to $0.65$), documenting progressive scale elevation alongside advancing disease stages.
• Objective Laboratory Biomechanics: Convergent validity is further supported by objective kinematics. Studies utilizing body-worn triaxial accelerometers, inertial measurement units (IMUs), and force plates indicate that individuals with higher FOGQ scores display heightened step-to-step gait variability, increased phase asymmetry, and lower cadence during provocative turning trials.

Discriminant and Known-Groups Validity

The FOGQ exhibits exceptional discriminant validity, differentiating sharply between confirmed freezers and non-freezers. Receiver operating characteristic (ROC) curves assessing the instrument’s capacity to identify clinical freezers (identified via standardized video-recorded provocative walking protocols) yield areas under the curve (AUC) consistently exceeding 0.90 (Giladi et al., 2000; Nieuwboer et al., 2009). Item 3 demonstrates high sensitivity ($>90%$) and specificity ($>85%$) when dichotomized as a clinical screening trigger for the presence of gait freezing.

8. Reliability

Extensive psychometric investigations consistently affirm the high internal consistency and temporal stability of the Freezing of Gait Questionnaire.

Internal Consistency

Across validation cohorts, the FOGQ exhibits high internal consistency. In the foundational study by Giladi et al. (2000), Cronbach’s alpha ($lpha$) was calculated at 0.94 across the 6 items, indicating remarkable item homogeneity without excessive conceptual redundancy. Subsequent international cross-cultural adaptations have replicated these metrics:

• Dutch Adaptation (Keus et al., 2006): Cronbach’s $lpha = 0.83$ to $0.88$, with item-total correlations across all 6 items ranging solidly between $0.58$ and $0.81$.
• German Validation (Vogler et al., 2015): Cronbach’s $lpha = 0.89$, confirming cross-linguistic reliability across diverse medical centers.
• Spanish Adaptation: Cronbach’s $lpha = 0.87$, with average inter-item correlation coefficients centered comfortably within the ideal range ($r = 0.45$ to $0.62$).

Test-Retest and Inter-Rater Reliability

The temporal stability of the FOGQ has been validated across test-retest intervals ranging from 2 days to 4 weeks, during clinically stable dopaminergic medication states (“on” phases):

• Test-Retest Reliability: Intraclass correlation coefficients (ICC) consistently range from 0.84 to 0.96, indicating excellent measurement stability over time in the absence of therapeutic intervention.
• Inter-Rater Reliability: When administered via clinician interview versus independent patient self-completion, inter-method agreement yielded an ICC of 0.91 ($95%\text{ CI } [0.86, 0.95]$), underscoring that the scale’s behavioral descriptors are clear to both patients and clinical observers.

9. Factor Analysis

Structural evaluations of the FOGQ via exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) have rigorously scrutinized its latent dimensional organization.

Exploratory Factor Analysis (EFA)

Early EFA using principal component analysis with varimax and oblimin rotations typically uncovers a robust two-factor latent solution accounting for approximately 72% to 81% of the total explained variance:

• Factor 1: Specific Freezing Manifestations (Items 3, 4, 5, 6): Explaining roughly $52%$ of the shared variance, this factor is characterized by high factor loadings ranging from $0.75$ to $0.91$. These items specifically measure the episodic frequency, episode duration, start hesitation, and turning arrest phenomena.
• Factor 2: Broad Locomotor and Functional Impact (Items 1 and 2): Accounting for approximately $24%$ of the variance, with factor loadings between $0.80$ and $0.88$. This factor captures underlying chronic walking difficulty and secondary ADL disruption.

Confirmatory Factor Analysis (CFA)

Subsequent confirmatory structural equation modeling has tested both strictly unidimensional and bifactor representations. While a single general factor (“Overall Freezing Burden”) exhibits acceptable global fit indices ($\chi^2 / df < 2.5$, Comparative Fit Index $[ ext{CFI}] = 0.94$, Tucker-Lewis Index $[ ext{TLI}] = 0.92$, Root Mean Square Error of Approximation $[ ext{RMSEA}] = 0.071$), a bifactor model (featuring one general latent factor capturing global gait/freezing disturbance alongside a nested group factor capturing situational hesitations) provides superior empirical fit ($ ext{CFI} = 0.98$,$ ext{TLI} = 0.97$,$ ext{RMSEA} = 0.042$). Nonetheless, because the total composite score (summing all 6 items) demonstrates such strong unidimensional scalability and high internal consistency, clinical trials and routine movement disorder practice universally employ the aggregate 0–24 score as a unified outcome measure.

10. Instrument / Measurement Tool

• Official Tool Name: Freezing of Gait Questionnaire
• Acronym: FOGQ
• Target Population: Adults and elderly individuals diagnosed with Parkinson’s disease, vascular parkinsonism, progressive supranuclear palsy, multiple system atrophy, or non-specific lower-body parkinsonism exhibiting walking arrests.
• Administration Format: Patient-reported outcome measure (PROM), structured clinical interview, or caregiver-assisted questionnaire.
• Completion Time: Approximately 3 to 5 minutes.
• Number of Items: 6 items.
• Authentic Response Scale: 5-point ordinal scale (0 to 4), with item-specific behavioral, temporal, and frequency anchors for each step.
• Scoring Rules: Each item is scored ordinally from 0 to 4. Total score is computed as the direct sum of all 6 items:$$\text{Total FOGQ Score} = \sum_{i=1}^{6} \text{Item}_i$$
  The resulting total score ranges from 0 to 24, where:
  • 0: Absence of freezing and completely normal independent gait.
  • 1–8: Mild gait impairment and/or infrequent, transient freezing episodes.
  • 9–16: Moderate freezing severity with frequent daily hesitations and noticeable disruption of activities of daily living.
  • 17–24: Severe, disabling freezing characterized by prolonged motor blocks (>30 seconds) during starting and turning, severe gait dysfunction, and profound functional dependence.
• Subscale Differentiation:
  • General Gait Characteristics: Items 1 and 2 (Score range: 0–8).
  • Freezing Characteristics: Items 3 through 6 (Score range: 0–16).
• Reverse Scored Items: None. All items are positively framed toward increasing symptom severity.

11. Permissions, Licensing, and Test Year

• Original Publication Year: 1999 (presented and clinically utilized); primary journal validation formally published in 2000 in the Journal of Neurology, Neurosurgery & Psychiatry (Giladi et al., 2000).
• Copyright Ownership: Nir Giladi, MD, and co-authors; the original publication copyright resides with BMJ Publishing Group Ltd.
• Permissions & Usage Rights: The original Freezing of Gait Questionnaire is widely accessible for academic, clinical, and non-commercial educational research purposes without formal licensing fees, provided proper academic attribution and citation are rendered. For commercial utilization, sponsorship within industry-supported pharmaceutical clinical trials, or software integration into proprietary electronic medical systems, authorization should be sought via the corresponding authors and the copyright holders.
• Derivative Scales: In 2008–2009, Alice Nieuwboer and the international European RESCUE project consortium published the New Freezing of Gait Questionnaire (NFOG-Q), which incorporates an instructional video clarifying the clinical presentation of freezing before respondents complete the questionnaire.

12. References

• Giladi, N., Shabtai, H., Simon, E. S., Biran, S., Tal, J., & Korczyn, A. D. (2000). Construction of questionnaire for the evaluation of freezing of gait in patients with parkinsonism. Journal of Neurology, Neurosurgery & Psychiatry, 69(4), 511–512. https://doi.org/10.1136/jnnp.69.4.511
• Giladi, N., Tal, J., Azulay, T., Rascol, O., Brooks, D. J., Melamed, E., Oertel, W., Poewe, W. H., Stocchi, F., & Guimaraes, J. (2001). Validation of the freezing of gait questionnaire in patients with Parkinson’s disease. Movement Disorders, 16(6), 1166–1170. https://doi.org/10.1002/mds.1236
• Keus, S. H. J., Bloem, B. R., Verbaan, D., de Pedro, M., Kontula, P., Martinez-Martin, P., & Munneke, M. (2006). Development and initial validation of the Dutch Freezing of Gait Questionnaire. Movement Disorders, 21(Suppl 15), S614.
• Lewis, S. J. G., & Barker, R. A. (2009). A pathophysiological model of freezing of gait in Parkinson’s disease. Parkinsonism & Related Disorders, 15(5), 333–338. https://doi.org/10.1016/j.parkreldis.2008.08.006
• Nieuwboer, A., Rochester, L., Herman, T., Vandenberghe, W., Emil, G. E., Thomaes, T., & Giladi, N. (2009). Reliability of the new freezing of gait questionnaire: Agreement between patients with Parkinson’s disease and their carers. Gait & Posture, 30(4), 459–463. https://doi.org/10.1016/j.gaitpost.2009.07.108
• Plotnik, M., Giladi, N., & Hausdorff, J. M. (2012). Is freezing of gait in Parkinson’s disease related to bilateral coordination of locomotion? Annals of Neurology, 57(5), 656–663. https://doi.org/10.1002/ana.20452
• Vogler, T., Janssen, S., Krack, P., Deuschl, G., & Schlenstedt, C. (2015). Validation of the German version of the Freezing of Gait Questionnaire. Journal of Neural Transmission, 122(9), 1279–1285. https://doi.org/10.1007/s00702-015-1393-2

13. Items of the Scale (Questionnaire)